<!DOCTYPE html>
<html lang="en"><head>
<script src="site_libs/clipboard/clipboard.min.js"></script>
<script src="site_libs/quarto-html/tabby.min.js"></script>
<script src="site_libs/quarto-html/popper.min.js"></script>
<script src="site_libs/quarto-html/tippy.umd.min.js"></script>
<link href="site_libs/quarto-html/tippy.css" rel="stylesheet">
<link href="site_libs/quarto-html/light-border.css" rel="stylesheet">
<link href="site_libs/quarto-html/quarto-syntax-highlighting-d4d76bf8491c20bad77d141916dc28e1.css" rel="stylesheet" id="quarto-text-highlighting-styles"><meta charset="utf-8">
  <meta name="generator" content="quarto-1.6.43">

  <title>talks – Sarcopenia in Colorectal Cancer</title>
  <meta name="apple-mobile-web-app-capable" content="yes">
  <meta name="apple-mobile-web-app-status-bar-style" content="black-translucent">
  <meta name="viewport" content="width=device-width, initial-scale=1.0, maximum-scale=1.0, user-scalable=no, minimal-ui">
  <link rel="stylesheet" href="site_libs/revealjs/dist/reset.css">
  <link rel="stylesheet" href="site_libs/revealjs/dist/reveal.css">
  <style>
    code{white-space: pre-wrap;}
    span.smallcaps{font-variant: small-caps;}
    div.columns{display: flex; gap: min(4vw, 1.5em);}
    div.column{flex: auto; overflow-x: auto;}
    div.hanging-indent{margin-left: 1.5em; text-indent: -1.5em;}
    ul.task-list{list-style: none;}
    ul.task-list li input[type="checkbox"] {
      width: 0.8em;
      margin: 0 0.8em 0.2em -1em; /* quarto-specific, see https://github.com/quarto-dev/quarto-cli/issues/4556 */ 
      vertical-align: middle;
    }
    /* CSS for citations */
    div.csl-bib-body { }
    div.csl-entry {
      clear: both;
      margin-bottom: 0em;
    }
    .hanging-indent div.csl-entry {
      margin-left:2em;
      text-indent:-2em;
    }
    div.csl-left-margin {
      min-width:2em;
      float:left;
    }
    div.csl-right-inline {
      margin-left:2em;
      padding-left:1em;
    }
    div.csl-indent {
      margin-left: 2em;
    }  </style>
  <link rel="stylesheet" href="site_libs/revealjs/dist/theme/quarto-2f366650f320edcfcf53d73c80250a32.css">
  <link href="site_libs/revealjs/plugin/quarto-line-highlight/line-highlight.css" rel="stylesheet">
  <link href="site_libs/revealjs/plugin/reveal-menu/menu.css" rel="stylesheet">
  <link href="site_libs/revealjs/plugin/reveal-menu/quarto-menu.css" rel="stylesheet">
  <link href="site_libs/revealjs/plugin/quarto-support/footer.css" rel="stylesheet">
  <style type="text/css">
    .reveal div.sourceCode {
      margin: 0;
      overflow: auto;
    }
    .reveal div.hanging-indent {
      margin-left: 1em;
      text-indent: -1em;
    }
    .reveal .slide:not(.center) {
      height: 100%;
    }
    .reveal .slide.scrollable {
      overflow-y: auto;
    }
    .reveal .footnotes {
      height: 100%;
      overflow-y: auto;
    }
    .reveal .slide .absolute {
      position: absolute;
      display: block;
    }
    .reveal .footnotes ol {
      counter-reset: ol;
      list-style-type: none; 
      margin-left: 0;
    }
    .reveal .footnotes ol li:before {
      counter-increment: ol;
      content: counter(ol) ". "; 
    }
    .reveal .footnotes ol li > p:first-child {
      display: inline-block;
    }
    .reveal .slide ul,
    .reveal .slide ol {
      margin-bottom: 0.5em;
    }
    .reveal .slide ul li,
    .reveal .slide ol li {
      margin-top: 0.4em;
      margin-bottom: 0.2em;
    }
    .reveal .slide ul[role="tablist"] li {
      margin-bottom: 0;
    }
    .reveal .slide ul li > *:first-child,
    .reveal .slide ol li > *:first-child {
      margin-block-start: 0;
    }
    .reveal .slide ul li > *:last-child,
    .reveal .slide ol li > *:last-child {
      margin-block-end: 0;
    }
    .reveal .slide .columns:nth-child(3) {
      margin-block-start: 0.8em;
    }
    .reveal blockquote {
      box-shadow: none;
    }
    .reveal .tippy-content>* {
      margin-top: 0.2em;
      margin-bottom: 0.7em;
    }
    .reveal .tippy-content>*:last-child {
      margin-bottom: 0.2em;
    }
    .reveal .slide > img.stretch.quarto-figure-center,
    .reveal .slide > img.r-stretch.quarto-figure-center {
      display: block;
      margin-left: auto;
      margin-right: auto; 
    }
    .reveal .slide > img.stretch.quarto-figure-left,
    .reveal .slide > img.r-stretch.quarto-figure-left  {
      display: block;
      margin-left: 0;
      margin-right: auto; 
    }
    .reveal .slide > img.stretch.quarto-figure-right,
    .reveal .slide > img.r-stretch.quarto-figure-right  {
      display: block;
      margin-left: auto;
      margin-right: 0; 
    }
  </style>
</head>
<body class="quarto-light">
  <div class="reveal">
    <div class="slides">

<section id="title-slide" class="quarto-title-block center">
  <h1 class="title">Sarcopenia in Colorectal Cancer</h1>

<div class="quarto-title-authors">
</div>

</section>
<section>
<section id="colorectal-cancer" class="title-slide slide level1 center">
<h1>Colorectal Cancer</h1>

</section>
<section id="surgical-patients" class="slide level2">
<h2>Surgical Patients</h2>
<p>2100 patients with LOS for 1139.predictors of LOS: age, surgical approach, major complications (incidence rate ratio [IRR] 2.42; 95% confidence interval [CI] 2.18–2.68), study cohort, and three body composition profiles characterized by myosteatosis combined with either sarcopenia (IRR, 1.27; 95% CI 1.12–1.43) or VO (IRR, 1.25; 95% CI 1.10–1.42), and myosteatosis combined with both sarcopenia and VO (IRR, 1.58; 95% CI 1.29–1.93). risk of readmission was associated with VO alone (odds ratio [OR] 2.66; 95% CI 1.18–6.00); P = 0.018), VO combined with myosteatosis (OR, 2.72; 95% CI 1.36–5.46; P = 0.005), or VO combined with myosteatosis and sarcopenia (OR, 2.98; 95% CI 1.06–5.46; P = 0.038). Importantly, the effect of body composition profiles on LOS and readmission was independent of major complications” <span class="citation" data-cites="martin2669">(<a href="#/sarcopenia-and-inflammatory-bowel-disease" role="doc-biblioref" onclick="">Martin et al., 2018</a>)</span></p>
<p>Sarcopenia is associated with postoperative infection and delayed recovery from colorectal cancer resection surgery. Br J Cancer. 2012;107(6):931–6<span class="citation" data-cites="lieffers931">(<a href="#/sarcopenia-and-inflammatory-bowel-disease" role="doc-biblioref" onclick="">Lieffers et al., 2012</a>)</span></p>
</section></section>
<section>
<section id="utility-of-fully-automated-body-composition-measures-on-pretreatment-abdominal-ct-for-predicting-survival-in-patients-with-colorectal-cancer" class="title-slide slide level1 center">
<h1>Utility of Fully Automated Body Composition Measures on Pretreatment Abdominal CT for Predicting Survival in Patients With Colorectal Cancer</h1>
<p>1766 CRC CT scans portal venous phase at L3: VAT, SAT, and aortic calcifications. Higher mortality with lower muscle attenuation, lower SAT, and higher aortic calcium. Measures with highest 5-year AUCs for predicting survival in patients without (<em>n</em> = 1303) and with (<em>n</em> = 463) metastatic disease were muscle attenuation (0.666 and 0.701, respectively) and aortic calcium (0.677 and 0.689, respectively). A combination of muscle attenuation, SAT area, and aortic calcium yielded 5-year AUCs of 0.758 and 0.732 in patients without and with metastases, respectively. Risk of death was increased (<em>p</em> &lt; .05) in patients in the lowest quartile for muscle attenuation (hazard ratio [HR] = 1.55) and SAT area (HR = 1.81) and in the highest quartile for aortic calcium (HR = 1.37) and decreased (<em>p</em> &lt; .05) in patients in the highest quartile for VAT area (HR = 0.79) and SAT area (HR = 0.76). In 423 patients with available BMI, BMI did not significantly predict death (<em>p</em> = .75). <span class="citation" data-cites="lee371">(<a href="#/sarcopenia-and-inflammatory-bowel-disease" role="doc-biblioref" onclick="">Lee et al., 2023</a>)</span></p>
<p>142 colectomy patients, of whom 17 had sarcopenia showed sarcopenia predicted complications after colectomy<span class="citation" data-cites="huangO256">(<a href="#/sarcopenia-and-inflammatory-bowel-disease" role="doc-biblioref" onclick="">Huang et al., 2015</a>)</span>. However, addition of grip strength and low gait speed added to ability to predict postoperative complications.</p>
<p>Psoas muscle area associated with postop complications after colectomy <span class="citation" data-cites="jonesO20">(<a href="#/sarcopenia-and-inflammatory-bowel-disease" role="doc-biblioref" onclick="">Jones et al., 2015</a>)</span></p>
<p>124 laparoscopic colectomies. No difference in LOS, complications, or functional recovery (time to first flatus, oral diet tolerance and mobilization) depending upon sarcopenia.<span class="citation" data-cites="pedziwiatr779">(<a href="#/sarcopenia-and-inflammatory-bowel-disease" role="doc-biblioref" onclick="">Pędziwiatr et al., 2016</a>)</span></p>
<p>60 patients who underwent laparoscopic colorectal resection for primary colorectal cancer sarcopenia group (normalized total psoas muscle area in males, &lt;538 mm/m(2); in females, &lt;346 mm/m(2); n = 20) and nonsarcopenia group (n = 40). No significant differences in the overall rate of postoperative complications (20% vs.&nbsp;20%) or major postoperative complications of Clavien-Dindo Grade III or more (5% vs.&nbsp;5%) were observed <span class="citation" data-cites="ouchi366">(<a href="#/sarcopenia-and-inflammatory-bowel-disease" role="doc-biblioref" onclick="">Ouchi et al., 2016</a>)</span></p>
<p>Muscle radiodensity and mortality in patients with colorectal cancer Kroenke 3008 pmid 29797673</p>
</section>
<section id="colectomy-for-colorectal-cancer" class="slide level2">
<h2>Colectomy for colorectal cancer</h2>
<p>Impact of sarcopenia on surgical and oncologic outcomes of laparoscopic surgery for colorectal cancer. Sarcopenia associated with readmission after colectomy for colorectal cancer 209 patients who underwent laparoscopic surgery for colorectal cancer. sarcopenia was 41.1%. Sarcopenic patients experienced shorter operative times and a lower incidence of surgical site infections; however, the incidence of severe postoperative complications and readmission were increased for this group. Although the 3-year disease-free survival rate was not statistically different between groups, sarcopenic patients had a significantly worse 3-year overall survival rate compared with than the non-sarcopenic group.<span class="citation" data-cites="takenami2686">(<a href="#/sarcopenia-and-inflammatory-bowel-disease" role="doc-biblioref" onclick="">Takenami et al., 2022</a>)</span></p>
</section>
<section id="colorectal-cancer-1" class="slide level2">
<h2>Colorectal Cancer</h2>
<p>Data from Kaiser <span class="citation" data-cites="xiao615">(<a href="#/sarcopenia-and-inflammatory-bowel-disease" role="doc-biblioref" onclick="">Xiao et al., 2019</a>)</span> examined 3263 patients with non-metastatic colorectal cancer. Black patients had higher lower rates of sarcopenia according to the definition of Prado et al.&nbsp;Patients with higher neutrophil-lymphocyte ratio had higher risk of muscle abnormality. CT scan at L3 was analyed to determine SMI,IMAT,VAT,SAT and TAT (=VAT+SAT+IMAT) using SliceOMatic. Threshold values determined for optimal stratification (cf <span class="citation" data-cites="martin1539">(<a href="#/sarcopenia-and-inflammatory-bowel-disease" role="doc-biblioref" onclick="">Martin et al., 2013</a>)</span> <span class="citation" data-cites="prado639">(<a href="#/sarcopenia-and-inflammatory-bowel-disease" role="doc-biblioref" onclick=""><strong>prado639?</strong></a>)</span></p>
<p>Kaiser 3262 patients with stage I-III colorectal cancer of whom 42% were sarcopenic. <span class="citation" data-cites="caan1008">(<a href="#/sarcopenia-and-inflammatory-bowel-disease" role="doc-biblioref" onclick="">Caan et al., 2017</a>)</span> examined body composition and survival from colorecal cncer at Kaiser. Worst survival with low muscle mass and high adiposity. Slightly worse survival with elevated VAT but no worse survival with increases SAT. Different relationships between TAT and survival by sex.</p>
<blockquote>
<p>The existence of nonlinear relationships between sarcopenia and body composition measures and overall mortality were assessed by the addition of restricted cubic splines and use of the likelihood ratio test that compared models with the linear terms only with those with both linear and cubic spline terms. Effect modification was assessed using cross-product terms for body composition measures and the following covariates: sex, age at diagnosis (&lt;60, 60–&lt;70, and 70 years), BMI category (18.5&lt;25, 25–&lt;30, and 30 kg/m2), weight change prior to diagnosis (stable, 5% loss, 5% gain), cancer stage (I, II/III), tumor site (rectal vs.&nbsp;colon), and chemotherapy (any vs.&nbsp;none).</p>
</blockquote>
<p>Trejo-Avila M, Bozada-Gutiérrez K, Valenzuela-Salazar C, Herrera-Esquivel J, Moreno-Portillo M. Sarcopenia predicts worse postoperative outcomes and decreased survival rates in patients with colorectal cancer: a systematic review and meta-analysis. Int J Colorectal Dis. 2021;36(6):1077–96. doi:&nbsp;10.1007/s00384-021-03839-4</p>
<p>.Preoperative Assessment of Cancer in the Elderly (PACE): Audisio RA, Pope D, Ramesh HS, Gennari R, van Leeuwen BL, West C, et al.&nbsp;Shall we operate? Preoperative assessment in elderly cancer patients (PACE) can help. A SIOG surgical task force prospective study. Crit Rev Oncol Hematol. 2008;65:156–63</p>
<p>Heriot AG, Tekkis PP, Smith JJ, Cohen CR, Montgomery A, Audisio RA, et al.&nbsp;Prediction of postoperative mortality in elderly patients with colorectal cancer. Dis Colon Rectum. 2006;49:816–24</p>
<p>Pope D, Ramesh H, Gennari R, Corsini G, Maffezzini M, Hoekstra HJ, et al.&nbsp;Pre-operative assessment of cancer in the elderly (PACE): a comprehensive assessment of underlying characteristics of elderly cancer patients prior to elective surgery. Surg Oncol. 2006;15:189–97</p>
<h3 id="sarcopenia-and-advanced-crc">Sarcopenia and advanced CRC</h3>
<p>French investigators studied 51 patients with mCRC and found sarcopenia in 70% (39% of women and 82% of men). In multivariate analysis including age, sex, BMI, sarcopenia, SAT, and VAT, the only factor associated with Grade 3-4 toxicities was sarcopenia (odds ratio = 13.55; 95% confidence interval [1.08; 169.31], P = 0.043).<span class="citation" data-cites="barrett583">(<a href="#/sarcopenia-and-inflammatory-bowel-disease" role="doc-biblioref" onclick=""><strong>barrett583?</strong></a>)</span></p>
<p>Data from Kaiser <span class="citation" data-cites="xiao615">(<a href="#/sarcopenia-and-inflammatory-bowel-disease" role="doc-biblioref" onclick="">Xiao et al., 2019</a>)</span> examined 3263 patients with non-metastatic colorectal cancer. Black patients had higher lower rates of sarcopenia according to the definition of Prado et al.&nbsp;Patients with higher neutrophil-lymphocyte ratio had higher risk of muscle abnormality. CT scan at L3 was analyed to determine SMI,IMAT,VAT,SAT and TAT (=VAT+SAT+IMAT) using SliceOMatic. Threshold values determined for optimal stratification (cf <span class="citation" data-cites="martin1539 prado639">(<a href="#/sarcopenia-and-inflammatory-bowel-disease" role="doc-biblioref" onclick="">Martin et al., 2013</a>; <a href="#/sarcopenia-and-inflammatory-bowel-disease" role="doc-biblioref" onclick=""><strong>prado639?</strong></a>)</span></p>
<p>Low muscle mass has been shown to be associated with poor prognosis cancer patients.<span class="citation" data-cites="martin1539">(<a href="#/sarcopenia-and-inflammatory-bowel-disease" role="doc-biblioref" onclick="">Martin et al., 2013</a>)</span> This may be due to overal frailty or low muscle mass may lead to increased toxicity from chemotherapy due to pharmacokinetic mechanism. 5-FU is hydrophilic and it volume of distribution includes the muscle compartment, while oxaliplatin is hydrophobic, with distribution in the fat compartment<span class="citation" data-cites="bozzetti2107">(<a href="#/sarcopenia-and-inflammatory-bowel-disease" role="doc-biblioref" onclick="">Bozzetti, 2017</a>)</span>.</p>
<p>In addition, loss of muscle mass during chemotherapy for advanced cancers is a poor prognosticator.</p>
<p>Blauhoff <span class="citation" data-cites="blauwhoff-buskermolen1339">(<a href="#/sarcopenia-and-inflammatory-bowel-disease" role="doc-biblioref" onclick="">Blauwhoff-Buskermolen et al., 2016</a>)</span> studis 67 patients with metastatic colorectal cancer. Muscle area on CT decreased by 6.1% over 3 months. Patients in the lowest tertile (loss of 9%) had worse survial. Overall survival 17.5 months for first-line chemotherapy and 8.5months for second-line. Baseline muscle density was predictive of survival on multivariable analysis, but low SMI at baseline was not associatesd with survival. (This may be because sarcopenic obesity is the major risk factor, and there were few obese patients in the study cohort) &gt;Muscle loss of 9% or more remained independently associated with survival when adjusted for sex, age, baseline lactate dehydrogenase concentration, comorbidity, mono-organ or multiorgan metastases, treatment line, and tumor progression at first evaluation by computed tomography scan (hazard ratio, 4.47; 95% CI, 2.21 to 9.05; P , .001). We found a mean coefficient of variation between observers of 0.6% for skeletal muscle area in a random sample of 20 patients, which is regarded to be low.<span class="citation" data-cites="macdonald342">(<a href="#/sarcopenia-and-inflammatory-bowel-disease" role="doc-biblioref" onclick="">MacDonald et al., 2011</a>)</span>. Changes between the first and second scans were calculated as a rate of change per 3 months, meaning change per first evaluation, to compare with available literature.[awad74][prado1583]Relative muscle change per 3 months was categorized into tertiles of muscle change: tertile one, highest muscle loss up to 9%; tertile two, muscle loss of 9% to 1.5%; and tertile three, muscle loss of 1.5% until highest gain in muscle. However, the survival curve of tertile two was not significantly different from the survival curve of tertile three (log-rank P = .961); therefore tertiles two and three were pooled (cutoff, 9% muscle loss).</p>
<p>Kurk <span class="citation" data-cites="kurk1033">(<a href="#/sarcopenia-and-inflammatory-bowel-disease" role="doc-biblioref" onclick="">Kurk et al., 2020</a>)</span> found that skeletal muscle loss during chemotherapy was associated with decreased progression-free and overall- survival in metastatic colorectal cancer.</p>
<blockquote>
<p>Detailed changes in skeletal muscle mass and body weight during CAIRO3 treatments were previously reported.KurkS, p909, 2018) We additionally analyzed changes in SMI and BMI during these treatments by linear mixed effects models.(Bayar MA,p311,2017) The baseline value of the outcome (SMI/BMI) was included in the outcome vector. Potential confounders were age, sex, lactate dehydrogenase (LDH) levels, best response to initial six cycles CAPOX‐B, resection of the primary tumor, and the number of metastatic sites. The final model was selected based on the Akaike Information Criterion (AIC) and included: treatment arm, time, age, sex, resection primary tumor, and the interaction of treatment arm by time as fixed effects. Modeling time as a random effect did not increase the model fit as indicated by the AIC. To investigate differences in SMI and BMI changes over time between the CAIRO3 treatment arms, we checked the significance of the two‐way interaction including treatment arm by time.</p>
</blockquote>
<blockquote>
<p>During p2 (maintenance CAP‐B/observation), again absolute SMI and BMI at the start (t1) of treatment were not associated with early progression and death. In contrast, SMI loss and BMI loss during treatment were associated with early progression and death.</p>
</blockquote>
<p>Fogelman <span class="citation" data-cites="fogelman307">(<a href="#/sarcopenia-and-inflammatory-bowel-disease" role="doc-biblioref" onclick="">Fogelman et al., 2014</a>)</span> treated patients undergoing chemotherapy with a novel agent designed to reduce muscle less. CT scans at 2 months were compared with baseline scans prior to chemotherapy.</p>
<blockquote>
<p>Changes in skeletal muscle were determined using routinely acquired CT scans for patients on the study. We calculated skeletal muscle cross-sectional area (cm2) at the third lumbar vertebra (L3). A single slice at the mid-point of L3 was used, preferably a 2.5-mm slice if available, and a 5-mm slice if a 2.5-mm slice was not available. The L3 is a landmark that has been extensively used and validated in studies assessing body composition in cancer patients [<span class="citation" data-cites="shen2333">Shen et al. (<a href="#/sarcopenia-and-inflammatory-bowel-disease" role="doc-biblioref" onclick="">2004</a>)</span>]<span class="citation" data-cites="prado269">(<a href="#/sarcopenia-and-inflammatory-bowel-disease" role="doc-biblioref" onclick="">Prado et al., 2009</a>)</span> . Skeletal muscle surface areas were determined using Slice-o-Matic softwareTM, version 4.3 (Tomovision, Montreal, QC, Canada) using pre-established thresholds of Hounsfield units (HU) of −29 to +150 <span class="citation" data-cites="mitsiopoulos115">(<a href="#/sarcopenia-and-inflammatory-bowel-disease" role="doc-biblioref" onclick="">Mitsiopoulos et al., 1998</a>)</span>. We additionally evaluated adipose tissue cross-sectional area (subcutaneous, visceral, and intramuscular) in the L3 region as described previously <span class="citation" data-cites="mourtzakis997">(<a href="#/sarcopenia-and-inflammatory-bowel-disease" role="doc-biblioref" onclick="">Mourtzakis et al., 2008</a>)</span>. Changes in muscle and adipose tissue surface areas over time were determined for each patient from the baseline study to the first CT post treatment, done after 2 months. We looked at muscle loss as a continuous variable and defined “meaningful loss” as greater than a 6 cm2 difference from the baseline to the second scan. We chose this cut point as it is equivalent to 1 kg of skeletal muscle and is associated with physical function (i.e., muscle strength). Additionally, this cut point has been used to investigate significant changes in muscle mass throughout cancer disease trajectory [<span class="citation" data-cites="shen2333">Shen et al. (<a href="#/sarcopenia-and-inflammatory-bowel-disease" role="doc-biblioref" onclick="">2004</a>)</span>]<span class="citation" data-cites="frontera1038">(<a href="#/sarcopenia-and-inflammatory-bowel-disease" role="doc-biblioref" onclick="">Frontera et al., 1988</a>)</span><span class="citation" data-cites="prado1012">(<a href="#/sarcopenia-and-inflammatory-bowel-disease" role="doc-biblioref" onclick="">Prado et al., 2013</a>)</span>.</p>
</blockquote>
<p>Prado <span class="citation" data-cites="prado1012">(<a href="#/sarcopenia-and-inflammatory-bowel-disease" role="doc-biblioref" onclick="">Prado et al., 2013</a>)</span> looked at changes in 1279 CT scans in 368 patients with advanced cancer. The last available interval with CT scans was chosen for comparison. Categorized into stable, gaining, losing for muscle and for adipose tissue. Adipose tissue was ?? sum of visceral adipose tissue and subcutaneous tissue. (<strong>Did not use SMI</strong>). Muscel loss and adipose loss seemed correlated, with larger magnitude of adipose tissue loss at short interval to death. (Authors conclusion that muscle and adipose tissue loss in the past 3 months of life is likely not possible) &gt;Advanced-cancer patients (n = 368; median survival: 196 d) had a total of 1279 CT images over the course of their disease. With consideration of all time points, muscle loss occurred in 39% of intervals between any 2 scans. However, the overall frequency of muscle gain was 15.4%, and muscle was stable in 45.6% of intervals between any 2 scans, which made the maintenance or gain of muscle the predominant behavior. Multinomial logistic regression revealed that being within 90 d (compared with &gt;90 d) from death was the principal risk factor for muscle loss (OR: 2.67; 95% CI: 1.45, 4.94; P = 0.002), and muscle gain was correspondingly less likely (OR: 0.37; 95% CI: 0.20, 0.69; P = 0.002) at this time. Sex, age, BMI, and tumor group were not significant predictors of muscle loss or gain. A much higher proportion of men (61%) than women (31%) met the criteria for sarcopenia. Changes in muscle and adipose tissue over time were calculated as the absolute loss or gain of tissue area during each scan interval. The precision error of measurements was ~1.5% <span class="citation" data-cites="mourtzakis997">(<a href="#/sarcopenia-and-inflammatory-bowel-disease" role="doc-biblioref" onclick="">Mourtzakis et al., 2008</a>)</span> with a minimum detectable change of ~3 cm2. We attributed the change during each interval into the following categories: 1) muscle loss ≥6.0 cm2, 2) stable muscle ±5.9 cm2, or 3) muscle gain ≥6.0cm2. These cutoffs are equivalent to a loss or gain of ≥1 kg of skeletal muscle on a whole-body basis and are associated with alterations in muscle strength [<span class="citation" data-cites="shen2333">Shen et al. (<a href="#/sarcopenia-and-inflammatory-bowel-disease" role="doc-biblioref" onclick="">2004</a>)</span>]<span class="citation" data-cites="frontera1038">(<a href="#/sarcopenia-and-inflammatory-bowel-disease" role="doc-biblioref" onclick="">Frontera et al., 1988</a>)</span>. For adipose tissue, categories were based on the equivalence of 14.7 cm2 total fat at L3 and 1 kg tissue on a whole-body basis <span class="citation" data-cites="shen2333">(<a href="#/sarcopenia-and-inflammatory-bowel-disease" role="doc-biblioref" onclick="">Shen et al., 2004</a>)</span>; therefore, changes during each interval were categorized as 1) adipose tissue loss ≥14.7 cm2, 2) stable adipose tissue ±14.6 cm2, or 3) adipose tissue gain ≥14.7 cm2. CT scans were taken for the diagnosis, confirmation of stage, and follow-up of disease progression and treatment. With the understanding that cachexia evolves markedly in the end of life and to take advantage of repeated measures, we focused on patients with ≥2 CT images (2–6 images) on record during the year preceding their deaths (n = 368). A selection bias was not apparent in this sample; we showed that the sex distribution, age at death, survival time, primary tumor site, tumor morphology, and body-composition features (ie, muscle and adipose tissues) in patients who had only a single scan were not different from those of the overall cohort at an equal time to death (P &gt; 0.1). Patients included in the analysis (n = 368) were of advanced stage, and the median time to death of all groups was &lt;1 y.</p>
<p>Lieffers and advanced colorectal cancer: Found liver and spleen increased in size in terminal patients (causing increase in basal metabolic rate). Found more rapid muscle loss with progressive disease <span class="citation" data-cites="lieffers1173">(<a href="#/sarcopenia-and-inflammatory-bowel-disease" role="doc-biblioref" onclick="">Lieffers et al., 2009</a>)</span>. Different thresholds for VAT (-150 to -50) and SAT(-190 to -30). Also estimated muscel surface area using measurements 5cm above L4<span class="citation" data-cites="shen2333">(<a href="#/sarcopenia-and-inflammatory-bowel-disease" role="doc-biblioref" onclick="">Shen et al., 2004</a>)</span>. Most rapid change in body composition between 4 months and 1 month prior to death. &gt;14% of patients gained skeletal muscle during the year preceding death from colorectal cancer (+4.7 ± 5.4%/100 d).</p>
</section>
<section id="sarcopenia-and-inflammatory-bowel-disease" class="slide level2 smaller scrollable">
<h2>Sarcopenia and inflammatory bowel disease</h2>
<h3 id="inflammation-in-colorectal-cancer">Inflammation in Colorectal Cancer</h3>
<p><span class="citation" data-cites="felicianoe172319">(<a href="#/sarcopenia-and-inflammatory-bowel-disease" role="doc-biblioref" onclick="">Feliciano et al., 2017</a>)</span> PMID 28796857PMID 24122750PMID 24866483</p>
<p>Skeletal muscle index was strongly correlated with intestinal resection and postoperative complications in patients with Crohn’s disease.4, 5</p>


<div id="refs" class="references csl-bib-body hanging-indent" data-entry-spacing="0" role="list">
<div id="ref-blauwhoff-buskermolen1339" class="csl-entry" role="listitem">
Blauwhoff-Buskermolen, S., Versteeg, K.S., Schueren, M.A.E. de van der, Braver, N.R. den, Berkhof, J., Langius, J.A.E., Verheul, H.M.W., 2016. Loss of <span>Muscle</span> <span>Mass</span> <span>During</span> <span>Chemotherapy</span> <span>Is</span> <span>Predictive</span> for <span>Poor</span> <span>Survival</span> of <span>Patients</span> <span>With</span> <span>Metastatic</span> <span>Colorectal</span> <span>Cancer</span>. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 34, 1339–1344. https://vb3lk7eb4t.search.serialssolutions.com/?id=<a href="https://www.ncbi.nlm.nih.gov/pubmed/26903572">26903572</a>
</div>
<div id="ref-bozzetti2107" class="csl-entry" role="listitem">
Bozzetti, F., 2017. Forcing the vicious circle: Sarcopenia increases toxicity, decreases response to chemotherapy and worsens with chemotherapy. Annals of Oncology: Official Journal of the European Society for Medical Oncology 28, 2107–2118. https://vb3lk7eb4t.search.serialssolutions.com/?id=<a href="https://www.ncbi.nlm.nih.gov/pubmed/28911059">28911059</a>
</div>
<div id="ref-caan1008" class="csl-entry" role="listitem">
Caan, B.J., Meyerhardt, J.A., Kroenke, C.H., Alexeeff, S., Xiao, J., Weltzien, E., Feliciano, E.C., Castillo, A.L., Quesenberry, C.P., Kwan, M.L., Prado, C.M., 2017. Explaining the <span>Obesity</span> <span>Paradox</span>: <span>The</span> <span>Association</span> between <span>Body</span> <span>Composition</span> and <span>Colorectal</span> <span>Cancer</span> <span>Survival</span> (<span>C</span>-<span>SCANS</span> <span>Study</span>). Cancer Epidemiology, Biomarkers &amp; Prevention: A Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology 26, 1008–1015. https://vb3lk7eb4t.search.serialssolutions.com/?id=<a href="https://www.ncbi.nlm.nih.gov/pubmed/28506965">28506965</a>
</div>
<div id="ref-felicianoe172319" class="csl-entry" role="listitem">
Feliciano, E.M.C., Kroenke, C.H., Meyerhardt, J.A., Prado, C.M., Bradshaw, P.T., Kwan, M.L., Xiao, J., Alexeeff, S., Corley, D., Weltzien, E., Castillo, A.L., Caan, B.J., 2017. Association of <span>Systemic</span> <span>Inflammation</span> and <span>Sarcopenia</span> <span>With</span> <span>Survival</span> in <span>Nonmetastatic</span> <span>Colorectal</span> <span>Cancer</span>: <span>Results</span> <span>From</span> the <span>C</span> <span>SCANS</span> <span>Study</span>. JAMA oncology 3, e172319. https://vb3lk7eb4t.search.serialssolutions.com/?id=<a href="https://www.ncbi.nlm.nih.gov/pubmed/28796857">28796857</a>
</div>
<div id="ref-fogelman307" class="csl-entry" role="listitem">
Fogelman, D.R., Holmes, H., Mohammed, K., Katz, M.H.G., Prado, C.M., Lieffers, J., Garg, N., Varadhachary, G.R., Shroff, R., Overman, M.J., Garrett, C., Wolff, R.A., Javle, M., 2014. Does <span>IGFR1</span> inhibition result in increased muscle mass loss in patients undergoing treatment for pancreatic cancer? Journal of Cachexia, Sarcopenia and Muscle 5, 307–313. https://vb3lk7eb4t.search.serialssolutions.com/?id=<a href="https://www.ncbi.nlm.nih.gov/pubmed/24740741">24740741</a>
</div>
<div id="ref-frontera1038" class="csl-entry" role="listitem">
Frontera, W.R., Meredith, C.N., O’Reilly, K.P., Knuttgen, H.G., Evans, W.J., 1988. Strength conditioning in older men: Skeletal muscle hypertrophy and improved function. Journal of Applied Physiology (Bethesda, Md.: 1985) 64, 1038–1044. https://vb3lk7eb4t.search.serialssolutions.com/?id=<a href="https://www.ncbi.nlm.nih.gov/pubmed/3366726">3366726</a>
</div>
<div id="ref-huangO256" class="csl-entry" role="listitem">
Huang, D.-D., Wang, S.-L., Zhuang, C.-L., Zheng, B.-S., Lu, J.-X., Chen, F.-F., Zhou, C.-J., Shen, X., Yu, Z., 2015. Sarcopenia, as defined by low muscle mass, strength and physical performance, predicts complications after surgery for colorectal cancer. Colorectal Disease: The Official Journal of the Association of Coloproctology of Great Britain and Ireland 17, O256–264. https://vb3lk7eb4t.search.serialssolutions.com/?id=<a href="https://www.ncbi.nlm.nih.gov/pubmed/26194849">26194849</a>
</div>
<div id="ref-jonesO20" class="csl-entry" role="listitem">
Jones, K.I., Doleman, B., Scott, S., Lund, J.N., Williams, J.P., 2015. Simple psoas cross-sectional area measurement is a quick and easy method to assess sarcopenia and predicts major surgical complications. Colorectal Dis 17, O20–6. https://vb3lk7eb4t.search.serialssolutions.com/?id=<a href="https://www.ncbi.nlm.nih.gov/pubmed/25328119">25328119</a>
</div>
<div id="ref-kurk1033" class="csl-entry" role="listitem">
Kurk, S.A., Peeters, P.H.M., Dorresteijn, B., Jong, P.A. de, Jourdan, M., Creemers, G.-J.M., Erdkamp, F.L.G., Jongh, F.E. de, Kint, P.A.M., Poppema, B.J., Radema, S.A., Simkens, L.H.J., Tanis, B.C., Tjin-A-Ton, M.L.R., Van Der Velden, A., Punt, C.J.A., Koopman, M., May, A.M., 2020. Loss of skeletal muscle index and survival in patients with metastatic colorectal cancer: <span>Secondary</span> analysis of the phase 3 <span>CAIRO3</span> trial. Cancer Medicine 9, 1033–1043. https://vb3lk7eb4t.search.serialssolutions.com/?id=<a href="https://www.ncbi.nlm.nih.gov/pubmed/31850687">31850687</a>
</div>
<div id="ref-lee371" class="csl-entry" role="listitem">
Lee, M.H., Pickhardt, S.G., Garrett, J.W., Perez, A.A., Zea, R., Valle, K.F., Lubner, M.G., Bates, D.D.B., Summers, R.M., Pickhardt, P.J., 2023. Utility of <span>Fully</span> <span>Automated</span> <span>Body</span> <span>Composition</span> <span>Measures</span> on <span>Pretreatment</span> <span>Abdominal</span> <span>CT</span> for <span>Predicting</span> <span>Survival</span> in <span>Patients</span> <span>With</span> <span>Colorectal</span> <span>Cancer</span>. AJR. American journal of roentgenology 220, 371–380. https://vb3lk7eb4t.search.serialssolutions.com/?id=<a href="https://www.ncbi.nlm.nih.gov/pubmed/36000663">36000663</a>
</div>
<div id="ref-lieffers931" class="csl-entry" role="listitem">
Lieffers, J.R., Bathe, O.F., Fassbender, K., Winget, M., Baracos, V.E., 2012. Sarcopenia is associated with postoperative infection and delayed recovery from colorectal cancer resection surgery. British Journal of Cancer 107, 931–936. https://vb3lk7eb4t.search.serialssolutions.com/?id=<a href="https://www.ncbi.nlm.nih.gov/pubmed/22871883">22871883</a>
</div>
<div id="ref-lieffers1173" class="csl-entry" role="listitem">
Lieffers, J.R., Mourtzakis, M., Hall, K.D., McCargar, L.J., Prado, C.M.M., Baracos, V.E., 2009. A viscerally driven cachexia syndrome in patients with advanced colorectal cancer: Contributions of organ and tumor mass to whole-body energy demands. The American Journal of Clinical Nutrition 89, 1173–1179. https://vb3lk7eb4t.search.serialssolutions.com/?id=<a href="https://www.ncbi.nlm.nih.gov/pubmed/19244378">19244378</a>
</div>
<div id="ref-macdonald342" class="csl-entry" role="listitem">
MacDonald, A.J., Greig, C.A., Baracos, V., 2011. The advantages and limitations of cross-sectional body composition analysis. Current Opinion in Supportive and Palliative Care 5, 342–349. https://vb3lk7eb4t.search.serialssolutions.com/?id=<a href="https://www.ncbi.nlm.nih.gov/pubmed/21986910">21986910</a>
</div>
<div id="ref-martin1539" class="csl-entry" role="listitem">
Martin, L., Birdsell, L., Macdonald, N., Reiman, T., Clandinin, M.T., McCargar, L.J., Murphy, R., Ghosh, S., Sawyer, M.B., Baracos, V.E., 2013. Cancer cachexia in the age of obesity: Skeletal muscle depletion is a powerful prognostic factor, independent of body mass index. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 31, 1539–1547. https://vb3lk7eb4t.search.serialssolutions.com/?id=<a href="https://www.ncbi.nlm.nih.gov/pubmed/23530101">23530101</a>
</div>
<div id="ref-martin2669" class="csl-entry" role="listitem">
Martin, L., Hopkins, J., Malietzis, G., Jenkins, J.T., Sawyer, M.B., Brisebois, R., MacLean, A., Nelson, G., Gramlich, L., Baracos, V.E., 2018. Assessment of <span>Computed</span> <span>Tomography</span> (<span>CT</span>)-<span>Defined</span> <span>Muscle</span> and <span>Adipose</span> <span>Tissue</span> <span>Features</span> in <span>Relation</span> to <span>Short</span>-<span>Term</span> <span>Outcomes</span> <span>After</span> <span>Elective</span> <span>Surgery</span> for <span>Colorectal</span> <span>Cancer</span>: <span>A</span> <span>Multicenter</span> <span>Approach</span>. Annals of Surgical Oncology 25, 2669–2680. https://vb3lk7eb4t.search.serialssolutions.com/?id=<a href="https://www.ncbi.nlm.nih.gov/pubmed/30006691">30006691</a>
</div>
<div id="ref-mitsiopoulos115" class="csl-entry" role="listitem">
Mitsiopoulos, N., Baumgartner, R.N., Heymsfield, S.B., Lyons, W., Gallagher, D., Ross, R., 1998. Cadaver validation of skeletal muscle measurement by magnetic resonance imaging and computerized tomography. Journal of Applied Physiology (Bethesda, Md.: 1985) 85, 115–122. https://vb3lk7eb4t.search.serialssolutions.com/?id=<a href="https://www.ncbi.nlm.nih.gov/pubmed/9655763">9655763</a>
</div>
<div id="ref-mourtzakis997" class="csl-entry" role="listitem">
Mourtzakis, M., Prado, C.M.M., Lieffers, J.R., Reiman, T., McCargar, L.J., Baracos, V.E., 2008. A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care. Applied Physiology, Nutrition, and Metabolism = Physiologie Appliquee, Nutrition Et Metabolisme 33, 997–1006. https://vb3lk7eb4t.search.serialssolutions.com/?id=<a href="https://www.ncbi.nlm.nih.gov/pubmed/18923576">18923576</a>
</div>
<div id="ref-ouchi366" class="csl-entry" role="listitem">
Ouchi, A., Asano, M., Aono, K., Watanabe, T., Oya, S., 2016. Laparoscopic <span>Colorectal</span> <span>Resection</span> in <span>Patients</span> with <span>Sarcopenia</span>: <span>A</span> <span>Retrospective</span> <span>Case</span>-<span>Control</span> <span>Study</span>. Journal of Laparoendoscopic &amp; Advanced Surgical Techniques. Part A 26, 366–370. https://vb3lk7eb4t.search.serialssolutions.com/?id=<a href="https://www.ncbi.nlm.nih.gov/pubmed/26982506">26982506</a>
</div>
<div id="ref-pedziwiatr779" class="csl-entry" role="listitem">
Pędziwiatr, M., Pisarska, M., Major, P., Grochowska, A., Matłok, M., Przęczek, K., Stefura, T., Budzyński, A., Kłęk, S., 2016. Laparoscopic colorectal cancer surgery combined with enhanced recovery after surgery protocol (<span>ERAS</span>) reduces the negative impact of sarcopenia on short-term outcomes. European Journal of Surgical Oncology: The Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 42, 779–787. https://vb3lk7eb4t.search.serialssolutions.com/?id=<a href="https://www.ncbi.nlm.nih.gov/pubmed/27156809">27156809</a>
</div>
<div id="ref-prado269" class="csl-entry" role="listitem">
Prado, C.M.M., Birdsell, L.A., Baracos, V.E., 2009. The emerging role of computerized tomography in assessing cancer cachexia. Current Opinion in Supportive and Palliative Care 3, 269–275. https://vb3lk7eb4t.search.serialssolutions.com/?id=<a href="https://www.ncbi.nlm.nih.gov/pubmed/19667996">19667996</a>
</div>
<div id="ref-prado1012" class="csl-entry" role="listitem">
Prado, C.M., Sawyer, M.B., Ghosh, S., Lieffers, J.R., Esfandiari, N., Antoun, S., Baracos, V.E., 2013. Central tenet of cancer cachexia therapy: Do patients with advanced cancer have exploitable anabolic potential? The American Journal of Clinical Nutrition 98, 1012–1019. https://vb3lk7eb4t.search.serialssolutions.com/?id=<a href="https://www.ncbi.nlm.nih.gov/pubmed/23966429">23966429</a>
</div>
<div id="ref-shen2333" class="csl-entry" role="listitem">
Shen, W., Punyanitya, M., Wang, Z., Gallagher, D., St-Onge, M.-P., Albu, J., Heymsfield, S.B., Heshka, S., 2004. Total body skeletal muscle and adipose tissue volumes: Estimation from a single abdominal cross-sectional image. Journal of Applied Physiology (Bethesda, Md.: 1985) 97, 2333–2338. https://vb3lk7eb4t.search.serialssolutions.com/?id=<a href="https://www.ncbi.nlm.nih.gov/pubmed/15310748">15310748</a>
</div>
<div id="ref-takenami2686" class="csl-entry" role="listitem">
Takenami, T., Tsujinaka, S., Miyakura, Y., Kakizawa, N., Maemoto, R., Machida, E., Hatsuzawa, Y., Takahashi, R., Kimura, Y., Tamaki, S., Ishikawa, H., Rikiyama, T., 2022. Impact of sarcopenia on surgical and oncologic outcomes of laparoscopic surgery for colorectal cancer. Asian Journal of Surgery 45, 2686–2690. https://vb3lk7eb4t.search.serialssolutions.com/?id=<a href="https://www.ncbi.nlm.nih.gov/pubmed/35221194">35221194</a>
</div>
<div id="ref-xiao615" class="csl-entry" role="listitem">
Xiao, J., Caan, B.J., Cespedes Feliciano, E.M., Meyerhardt, J.A., Kroenke, C.H., Baracos, V.E., Weltzien, E., Kwan, M.L., Alexeeff, S.E., Castillo, A.L., Prado, C.M., 2019. The association of medical and demographic characteristics with sarcopenia and low muscle radiodensity in patients with nonmetastatic colorectal cancer. The American Journal of Clinical Nutrition 109, 615–625. https://vb3lk7eb4t.search.serialssolutions.com/?id=<a href="https://www.ncbi.nlm.nih.gov/pubmed/30850836">30850836</a>
</div>
</div>
</section></section>
    </div>
  <div class="quarto-auto-generated-content" style="display: none;">
<div class="footer footer-default">

</div>
</div></div>

  <script>window.backupDefine = window.define; window.define = undefined;</script>
  <script src="site_libs/revealjs/dist/reveal.js"></script>
  <!-- reveal.js plugins -->
  <script src="site_libs/revealjs/plugin/quarto-line-highlight/line-highlight.js"></script>
  <script src="site_libs/revealjs/plugin/pdf-export/pdfexport.js"></script>
  <script src="site_libs/revealjs/plugin/reveal-menu/menu.js"></script>
  <script src="site_libs/revealjs/plugin/reveal-menu/quarto-menu.js"></script>
  <script src="site_libs/revealjs/plugin/quarto-support/support.js"></script>
  

  <script src="site_libs/revealjs/plugin/notes/notes.js"></script>
  <script src="site_libs/revealjs/plugin/search/search.js"></script>
  <script src="site_libs/revealjs/plugin/zoom/zoom.js"></script>
  <script src="site_libs/revealjs/plugin/math/math.js"></script>
  <script>window.define = window.backupDefine; window.backupDefine = undefined;</script>

  <script>

      // Full list of configuration options available at:
      // https://revealjs.com/config/
      Reveal.initialize({
'controlsAuto': true,
'previewLinksAuto': false,
'pdfSeparateFragments': false,
'autoAnimateEasing': "ease",
'autoAnimateDuration': 1,
'autoAnimateUnmatched': true,
'jumpToSlide': true,
'menu': {"side":"left","useTextContentForMissingTitles":true,"markers":false,"loadIcons":false,"custom":[{"title":"Tools","icon":"<i class=\"fas fa-gear\"></i>","content":"<ul class=\"slide-menu-items\">\n<li class=\"slide-tool-item active\" data-item=\"0\"><a href=\"#\" onclick=\"RevealMenuToolHandlers.fullscreen(event)\"><kbd>f</kbd> Fullscreen</a></li>\n<li class=\"slide-tool-item\" data-item=\"1\"><a href=\"#\" onclick=\"RevealMenuToolHandlers.speakerMode(event)\"><kbd>s</kbd> Speaker View</a></li>\n<li class=\"slide-tool-item\" data-item=\"2\"><a href=\"#\" onclick=\"RevealMenuToolHandlers.overview(event)\"><kbd>o</kbd> Slide Overview</a></li>\n<li class=\"slide-tool-item\" data-item=\"3\"><a href=\"#\" onclick=\"RevealMenuToolHandlers.togglePdfExport(event)\"><kbd>e</kbd> PDF Export Mode</a></li>\n<li class=\"slide-tool-item\" data-item=\"4\"><a href=\"#\" onclick=\"RevealMenuToolHandlers.toggleScrollView(event)\"><kbd>r</kbd> Scroll View Mode</a></li>\n<li class=\"slide-tool-item\" data-item=\"5\"><a href=\"#\" onclick=\"RevealMenuToolHandlers.keyboardHelp(event)\"><kbd>?</kbd> Keyboard Help</a></li>\n</ul>"}],"openButton":true},
'smaller': false,
 
        // Display controls in the bottom right corner
        controls: false,

        // Help the user learn the controls by providing hints, for example by
        // bouncing the down arrow when they first encounter a vertical slide
        controlsTutorial: false,

        // Determines where controls appear, "edges" or "bottom-right"
        controlsLayout: 'edges',

        // Visibility rule for backwards navigation arrows; "faded", "hidden"
        // or "visible"
        controlsBackArrows: 'faded',

        // Display a presentation progress bar
        progress: true,

        // Display the page number of the current slide
        slideNumber: false,

        // 'all', 'print', or 'speaker'
        showSlideNumber: 'all',

        // Add the current slide number to the URL hash so that reloading the
        // page/copying the URL will return you to the same slide
        hash: true,

        // Start with 1 for the hash rather than 0
        hashOneBasedIndex: false,

        // Flags if we should monitor the hash and change slides accordingly
        respondToHashChanges: true,

        // Push each slide change to the browser history
        history: true,

        // Enable keyboard shortcuts for navigation
        keyboard: true,

        // Enable the slide overview mode
        overview: true,

        // Disables the default reveal.js slide layout (scaling and centering)
        // so that you can use custom CSS layout
        disableLayout: false,

        // Vertical centering of slides
        center: false,

        // Enables touch navigation on devices with touch input
        touch: true,

        // Loop the presentation
        loop: false,

        // Change the presentation direction to be RTL
        rtl: false,

        // see https://revealjs.com/vertical-slides/#navigation-mode
        navigationMode: 'linear',

        // Randomizes the order of slides each time the presentation loads
        shuffle: false,

        // Turns fragments on and off globally
        fragments: true,

        // Flags whether to include the current fragment in the URL,
        // so that reloading brings you to the same fragment position
        fragmentInURL: false,

        // Flags if the presentation is running in an embedded mode,
        // i.e. contained within a limited portion of the screen
        embedded: false,

        // Flags if we should show a help overlay when the questionmark
        // key is pressed
        help: true,

        // Flags if it should be possible to pause the presentation (blackout)
        pause: true,

        // Flags if speaker notes should be visible to all viewers
        showNotes: false,

        // Global override for autoplaying embedded media (null/true/false)
        autoPlayMedia: null,

        // Global override for preloading lazy-loaded iframes (null/true/false)
        preloadIframes: null,

        // Number of milliseconds between automatically proceeding to the
        // next slide, disabled when set to 0, this value can be overwritten
        // by using a data-autoslide attribute on your slides
        autoSlide: 0,

        // Stop auto-sliding after user input
        autoSlideStoppable: true,

        // Use this method for navigation when auto-sliding
        autoSlideMethod: null,

        // Specify the average time in seconds that you think you will spend
        // presenting each slide. This is used to show a pacing timer in the
        // speaker view
        defaultTiming: null,

        // Enable slide navigation via mouse wheel
        mouseWheel: false,

        // The display mode that will be used to show slides
        display: 'block',

        // Hide cursor if inactive
        hideInactiveCursor: true,

        // Time before the cursor is hidden (in ms)
        hideCursorTime: 5000,

        // Opens links in an iframe preview overlay
        previewLinks: false,

        // Transition style (none/fade/slide/convex/concave/zoom)
        transition: 'none',

        // Transition speed (default/fast/slow)
        transitionSpeed: 'default',

        // Transition style for full page slide backgrounds
        // (none/fade/slide/convex/concave/zoom)
        backgroundTransition: 'none',

        // Number of slides away from the current that are visible
        viewDistance: 3,

        // Number of slides away from the current that are visible on mobile
        // devices. It is advisable to set this to a lower number than
        // viewDistance in order to save resources.
        mobileViewDistance: 2,

        // The "normal" size of the presentation, aspect ratio will be preserved
        // when the presentation is scaled to fit different resolutions. Can be
        // specified using percentage units.
        width: 1050,

        height: 700,

        // Factor of the display size that should remain empty around the content
        margin: 0.1,

        math: {
          mathjax: 'https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.9/MathJax.js',
          config: 'TeX-AMS_HTML-full',
          tex2jax: {
            inlineMath: [['\\(','\\)']],
            displayMath: [['\\[','\\]']],
            balanceBraces: true,
            processEscapes: false,
            processRefs: true,
            processEnvironments: true,
            preview: 'TeX',
            skipTags: ['script','noscript','style','textarea','pre','code'],
            ignoreClass: 'tex2jax_ignore',
            processClass: 'tex2jax_process'
          },
        },

        // reveal.js plugins
        plugins: [QuartoLineHighlight, PdfExport, RevealMenu, QuartoSupport,

          RevealMath,
          RevealNotes,
          RevealSearch,
          RevealZoom
        ]
      });
    </script>
    <script id="quarto-html-after-body" type="application/javascript">
    window.document.addEventListener("DOMContentLoaded", function (event) {
      const toggleBodyColorMode = (bsSheetEl) => {
        const mode = bsSheetEl.getAttribute("data-mode");
        const bodyEl = window.document.querySelector("body");
        if (mode === "dark") {
          bodyEl.classList.add("quarto-dark");
          bodyEl.classList.remove("quarto-light");
        } else {
          bodyEl.classList.add("quarto-light");
          bodyEl.classList.remove("quarto-dark");
        }
      }
      const toggleBodyColorPrimary = () => {
        const bsSheetEl = window.document.querySelector("link#quarto-bootstrap");
        if (bsSheetEl) {
          toggleBodyColorMode(bsSheetEl);
        }
      }
      toggleBodyColorPrimary();  
      const tabsets =  window.document.querySelectorAll(".panel-tabset-tabby")
      tabsets.forEach(function(tabset) {
        const tabby = new Tabby('#' + tabset.id);
      });
      const isCodeAnnotation = (el) => {
        for (const clz of el.classList) {
          if (clz.startsWith('code-annotation-')) {                     
            return true;
          }
        }
        return false;
      }
      const onCopySuccess = function(e) {
        // button target
        const button = e.trigger;
        // don't keep focus
        button.blur();
        // flash "checked"
        button.classList.add('code-copy-button-checked');
        var currentTitle = button.getAttribute("title");
        button.setAttribute("title", "Copied!");
        let tooltip;
        if (window.bootstrap) {
          button.setAttribute("data-bs-toggle", "tooltip");
          button.setAttribute("data-bs-placement", "left");
          button.setAttribute("data-bs-title", "Copied!");
          tooltip = new bootstrap.Tooltip(button, 
            { trigger: "manual", 
              customClass: "code-copy-button-tooltip",
              offset: [0, -8]});
          tooltip.show();    
        }
        setTimeout(function() {
          if (tooltip) {
            tooltip.hide();
            button.removeAttribute("data-bs-title");
            button.removeAttribute("data-bs-toggle");
            button.removeAttribute("data-bs-placement");
          }
          button.setAttribute("title", currentTitle);
          button.classList.remove('code-copy-button-checked');
        }, 1000);
        // clear code selection
        e.clearSelection();
      }
      const getTextToCopy = function(trigger) {
          const codeEl = trigger.previousElementSibling.cloneNode(true);
          for (const childEl of codeEl.children) {
            if (isCodeAnnotation(childEl)) {
              childEl.remove();
            }
          }
          return codeEl.innerText;
      }
      const clipboard = new window.ClipboardJS('.code-copy-button:not([data-in-quarto-modal])', {
        text: getTextToCopy
      });
      clipboard.on('success', onCopySuccess);
      if (window.document.getElementById('quarto-embedded-source-code-modal')) {
        const clipboardModal = new window.ClipboardJS('.code-copy-button[data-in-quarto-modal]', {
          text: getTextToCopy,
          container: window.document.getElementById('quarto-embedded-source-code-modal')
        });
        clipboardModal.on('success', onCopySuccess);
      }
        var localhostRegex = new RegExp(/^(?:http|https):\/\/localhost\:?[0-9]*\//);
        var mailtoRegex = new RegExp(/^mailto:/);
          var filterRegex = new RegExp("https:\/\/gisurgonc\.github\.io\/talks\/");
        var isInternal = (href) => {
            return filterRegex.test(href) || localhostRegex.test(href) || mailtoRegex.test(href);
        }
        // Inspect non-navigation links and adorn them if external
     	var links = window.document.querySelectorAll('a[href]:not(.nav-link):not(.navbar-brand):not(.toc-action):not(.sidebar-link):not(.sidebar-item-toggle):not(.pagination-link):not(.no-external):not([aria-hidden]):not(.dropdown-item):not(.quarto-navigation-tool):not(.about-link)');
        for (var i=0; i<links.length; i++) {
          const link = links[i];
          if (!isInternal(link.href)) {
            // undo the damage that might have been done by quarto-nav.js in the case of
            // links that we want to consider external
            if (link.dataset.originalHref !== undefined) {
              link.href = link.dataset.originalHref;
            }
          }
        }
      function tippyHover(el, contentFn, onTriggerFn, onUntriggerFn) {
        const config = {
          allowHTML: true,
          maxWidth: 500,
          delay: 100,
          arrow: false,
          appendTo: function(el) {
              return el.closest('section.slide') || el.parentElement;
          },
          interactive: true,
          interactiveBorder: 10,
          theme: 'light-border',
          placement: 'bottom-start',
        };
        if (contentFn) {
          config.content = contentFn;
        }
        if (onTriggerFn) {
          config.onTrigger = onTriggerFn;
        }
        if (onUntriggerFn) {
          config.onUntrigger = onUntriggerFn;
        }
          config['offset'] = [0,0];
          config['maxWidth'] = 700;
        window.tippy(el, config); 
      }
      const noterefs = window.document.querySelectorAll('a[role="doc-noteref"]');
      for (var i=0; i<noterefs.length; i++) {
        const ref = noterefs[i];
        tippyHover(ref, function() {
          // use id or data attribute instead here
          let href = ref.getAttribute('data-footnote-href') || ref.getAttribute('href');
          try { href = new URL(href).hash; } catch {}
          const id = href.replace(/^#\/?/, "");
          const note = window.document.getElementById(id);
          if (note) {
            return note.innerHTML;
          } else {
            return "";
          }
        });
      }
      const findCites = (el) => {
        const parentEl = el.parentElement;
        if (parentEl) {
          const cites = parentEl.dataset.cites;
          if (cites) {
            return {
              el,
              cites: cites.split(' ')
            };
          } else {
            return findCites(el.parentElement)
          }
        } else {
          return undefined;
        }
      };
      var bibliorefs = window.document.querySelectorAll('a[role="doc-biblioref"]');
      for (var i=0; i<bibliorefs.length; i++) {
        const ref = bibliorefs[i];
        const citeInfo = findCites(ref);
        if (citeInfo) {
          tippyHover(citeInfo.el, function() {
            var popup = window.document.createElement('div');
            citeInfo.cites.forEach(function(cite) {
              var citeDiv = window.document.createElement('div');
              citeDiv.classList.add('hanging-indent');
              citeDiv.classList.add('csl-entry');
              var biblioDiv = window.document.getElementById('ref-' + cite);
              if (biblioDiv) {
                citeDiv.innerHTML = biblioDiv.innerHTML;
              }
              popup.appendChild(citeDiv);
            });
            return popup.innerHTML;
          });
        }
      }
    });
    </script>
    

</body></html>